National Tunisian Registry of Cardiac Implantable Electronic Devices
NATURE-CIED
1 other identifier
observational
1,518
1 country
1
Brief Summary
The National Tunisian Registry of Cardiac Implantable Electronic Devices is an observational, prospective and multicenter study aiming to assess the epidemiological, clinical and therapeutic profile of cardiac implantable electronic Devices in Tunisia. Cardiologists from both sectors (public and private) are participating in the study, with 26 investigational centers. Data is captured electronically by DACIMA Clinical Suite, according to FDA 21 CFR part 11 (Food and Drug Administration 21 Code of Federal Regulations part 11), HIPAA (Health Insurance Portability and Accountability Act) \& ICH (International Conference on Harmonisation) requirements.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2021
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 18, 2021
CompletedFirst Submitted
Initial submission to the registry
April 30, 2022
CompletedFirst Posted
Study publicly available on registry
May 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 15, 2023
CompletedAugust 15, 2023
August 1, 2023
2.6 years
April 30, 2022
August 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence of patients undergoing cardiac implantable electronic devices in Tunisia
Number of subjects with heart disease (heart failure, rythm disorder) and willing to participate at the study and who are eligible for cardiac implantable electronic devices procedures
at inclusion
Secondary Outcomes (1)
Heart complication
at 12 months of follow-up
Interventions
Description of Cardiac Implantable Electronic Devices
Eligibility Criteria
Patients undergoing cardiac implantable electronic device procedure
You may qualify if:
- Patients originated from Tunisia
- Signed informed consent
- Patients undergoing a cardiac implantable electronic device procedure
You may not qualify if:
- Informed Consent not given
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Tunisian Society of Cardiology and CardioVascular Surgery
Tunis, 1053, Tunisia
Related Publications (1)
Chabrak S, Haggui A, Allouche E, Ouali S, Ben Halima A, Kacem S, Krichen S, Marrakchi S, Fehri W, Mourali MS, Jabbari Z, Ben Halima M, Neffati E, Heraiech A, Slim M, Kachboura S, Gamra H, Hassine M, Kraiem S, Kammoun S, Bezdah L, Jridi G, Bouraoui H, Kammoun S, Hammami R, Chettaoui R, Ben Ameur Y, Azaiez F, Tlili R, Battikh K, Ben Slima H, Chrigui R, Fazaa S, Sanaa I, Ellouz Y, Mosrati M, Milouchi S, Jarmouni S, Ayadi W, Akrout M, Razgallah R, Neffati W, Drissa M, Charfeddine S, Abdessalem S, Abid L, Zakhama L. National Tunisian Study of Cardiac Implantable Electronic Devices: Design and Protocol for a Nationwide Multicenter Prospective Observational Study. JMIR Res Protoc. 2024 Apr 8;13:e47525. doi: 10.2196/47525.
PMID: 38588529DERIVED
Related Links
Study Officials
- STUDY CHAIR
Sonia Chabrak, MD
Tunisian Society of Cardiology and Cardiovascular Surgery
- STUDY DIRECTOR
Abdeddayem Haggui, MD
Tunisian Society of Cardiology and Cardiovascular Surgery
- PRINCIPAL INVESTIGATOR
Salma Krichène, MD
Tunisian Society of Cardiology and Cardiovascular Surgery
- PRINCIPAL INVESTIGATOR
Slim Kacem, MD
Tunisian Society of Cardiology and Cardiovascular Surgery
- PRINCIPAL INVESTIGATOR
Sonia Marrakchi, MD
Tunisian Society of Cardiology and Cardiovascular Surgery
- PRINCIPAL INVESTIGATOR
Emna Allouche, MD
Tunisian Society of Cardiology and Cardiovascular Surgery
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 12 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 30, 2022
First Posted
May 5, 2022
Study Start
January 18, 2021
Primary Completion
August 15, 2023
Study Completion
August 15, 2023
Last Updated
August 15, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will not share